Introduction

T prolymphocytic leukemias (T-PLL) in humans often have chromosomal translocations
that juxtapose the TCR / or locus to the proximity of the T cell leukemia/lymphoma-1 gene (TCL1) located in the 14q32.1 region or, less frequently, to lie near its mature T cell proliferation 1 (MTCP 1) gene homolog in the Xq23 region [1] [2] [3] [4] . The ensuing aberrant influence of a TCR enhancer element results in overexpression of the TCL1 or MTCP1 genes 5, 6 . Overexpression of either TCL1 or MTCP1 in transgenic mouse models employing a T cell specific promoter may also result in a T cell leukemia that resembles human T-PLL 7, 8 . In addition to the implicit TCL1 involvement in this T cell malignancy, a variety of B lineage tumor cell lines, ranging from pre-B cell to mature B cell phenotype, have also been shown to express high Tcl1 levels [9] [10] [11] . Moreover, TCL1
overexpression under the control of B lineage specific enhancer and promoter elements has been shown to promote B cell chronic lymphocytic leukemia 12 and B cell lymphomas in mice 13 . 
Materials and Methods
Mice, cell preparation, cell counting, and statistical analysis
Tcl1
-/-and Tcl1 +/-mice were generated as described previously 20 . Bone marrow (BM) cells were obtained by flushing the cavities of both femoral and tibial bones with media.
Thymus and spleen samples were minced between frosted ends of glass slides. Cells suspended in media were then filtered through fine metal screens or Nylon membranes , and Tcl1 -/-mice was layered over lymphocyte separation medium (density 1.078 g/ml; Cellgro, Mediatech Inc, Herndon,
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From VA) and centrifuged to remove leukocytes and erythrocytes. Since there were no differences between wild type and heterozygous mice in lymphoid organ cellularity, we grouped wild type and heterozygous mouse data together. The total number of cells in each population was estimated by enumerating the nucleated cells by light microscopy and determining the percentage for each population by immunofluorescence. The statistical significance of population differences was calculated by a Student's 2-tailed ttest using the Excel program. 
Analysis of Tcl1 gene family transcripts
RNA was isolated from FACS-sorted subpopulations (96 -99 % purity) of lymphocytes from tissue samples using the TRI Reagent (Molecular Research Center, Cincinnati, OH) and dissolved in 20 µl of RNase-free distilled water (Ambion, Austin, TX). First-strand cDNA was synthesized from the isolated RNA (10 µl) using oligo(dT) 15 All the reactions were denatured at 94°C for 30"; annealed at the specific temperature for 30" and elongated at 72°C for 1'. Duplicates of a diluted serum sample were added and Ig isotypes were measured in serum samples by employing goat anti-mouse isotype specific antibodies conjugated with AP.
Anti-CD3 antibody treatment and immunizations
Isotype specific anti-SRBC antibodies were measured by fixing SRBC onto the plastic plate 21 . Anti-PC (phosphocholine) specific antibodies were similarly measured in plastic wells coated with PC-BSA (a gift from Dr. John Kearney, UAB).
Results
Tcl1 expression in normal lymphoid tissues
In an analysis of the lymphoid tissues from wild-type mice, Tcl1 transcripts could be 
Impaired T and B lymphopoiesis in Tcl1 deficient mice
Although the Tcl1 -/-mice have a fertilty defect that is manifested by reduced litter size 20 ,
the Tcl1 -/-newborns appeared normal and continued to develop normally. Histological examination of the lymphoid organs of the Tcl1 -/-mice did not reveal obvious developmental abnormalities, nor did we observe significant differences in organ size and total body weight (data not shown). However, reduced numbers of lymphocytes were found in the bone marrow, thymus and spleen ( (Fig. 2) . Notably, these data indicate that Tcl1 deficiency does not lead to a complete differentiation block in either lymphoid lineage.
Hypersensitivity of TCR-bearing thymocytes to CD3 ligation in Tcl1 -/-mice
Since earlier studies suggest roles for the human TCL1 gene product in cellular proliferation 7, 8 and in anti-apoptotic signaling 10,16,17 , we tested the effects of apoptotic and proliferative stimuli under in vivo and in vitro conditions. When the rate of spontaneous apoptosis was assessed by measuring cell viability in thymocytes cultured in media or for thymocytes stimulated with dexamethasone, significant differences were not observed for the wt and null mice (data not shown). We therefore examined the effect of TCR/CD3 ligation-induced apoptosis as a surrogate model for the negative clonal selection that occurs during thymocyte development 29, 30 . -/-mice than in control mice, whereas other immunoglobulin isotypes were not significantly affected (Table 3) . To assess antibody responsiveness to a thymus-dependent antigen, mice were immunized intravenously with sheep red blood cells (SRBC) and bled one week later. The levels of SRBC specific IgG1 and IgG2b antibodies in Tcl1 -/-mice were approximately 40% of those in the control mice (Fig. 4) . Tcl1 -/-and control mice (Fig. 4 A) Examination of the T-independent antibody response to the immunodominant phosphocholine epitope of S. pneumoniae 33, 34 indicated that the levels of IgM anti-PC specific antibodies produced in Tcl1 -/-mice were approximately 45% of those observed in control mice one week after immunization (Fig. 4 B) key residues in a way that would allow overall structural integrity could still disrupt TCL1/AKT-binding interactions 43 .
On the other hand, the phenotypical changes here described are consistent with those observed in other murine models of Akt transgenic or null mice. Akt has been functionally linked to B and T cell development in studies that have demonstrated the activation of Akt in response to both BCR-and TCR-receptor mediated signaling 14, 44, 45 .
Additional insight into this developmental role has been obtained in studies of animal models wherein Akt is overexpressed 46 or underexpressed 47 . Akt1 -/-mice display increased thymocyte apoptosis and hypersensitivity to apoptosis induction by gamma irradiation and dexamathasone treatment 47 . Conversely, immune system alteration in Akt transgenics is manifested by B and T cell hypercellularity, enhanced immunoglobulin levels, especially IgG2a and IgA, and increased resistance to FAS mediated apoptosis induced by CD3 stimulation 46 . Transgenic mice that overexpress either Tcl1 or its MTCP1 homologue also have exaggerated T and B cell proliferation and they develop leukemias 7, 8, 12, 13 . By contrast, Tcl1 deficient mice are shown in the present study to manifest precisely the opposite effects of those seen in Akt transgenic mice. It may therefore be of interest to cross these animal models in future studies to explore the coordinate roles of the Tcl1 and Akt genes in BCR/ TCR mediated signaling and clonal selection.
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